This company has been marked as potentially delisted and may not be actively trading. NASDAQ:IMRA IMARA (IMRA) Stock Price, News & Analysis Add Compare Share Share Stock Analysis Stock AnalysisCompetitorsInsider TradesTrendsBuy This Stock About IMARA Stock (NASDAQ:IMRA) 30 days 90 days 365 days Advanced Chart Get IMARA alerts:Sign Up Key Stats Today's Range$46.60▼$48.4150-Day Range$6.32▼$25.2852-Week Range$0.97▼$6.32Volume16,142 shsAverage Volume138,364 shsMarket Capitalization$1.24 billionP/E Ratio944.31Dividend YieldN/APrice TargetN/AConsensus RatingN/A Company OverviewIMARA Inc., a clinical-stage biopharmaceutical company, develops and commercializes therapeutics for patients with rare genetic disorders of hemoglobin. Its lead product candidate is IMR-687, an oral and once-a-day therapeutic that is in Phase 2b clinical trials for the treatment of sickle cell disease and ß-thalassemia. The company also develops IMR-261, an oral and clinical-ready activator of nuclear factor erythroid 2-related factor 2 for the treatment of hemoglobinopathies, iron disorders, and potentially other areas. IMARA Inc. was incorporated in 2016 and is headquartered in Boston, Massachusetts.Read More… Receive IMRA Stock News and Ratings via Email Sign-up to receive the latest news and ratings for IMARA and its competitors with MarketBeat's FREE daily newsletter. Email Address IMRA Stock News HeadlinesImara overcoming infertility, am I appalled with blood on my face, is it a pregnancy symptom?May 20, 2025 | msn.comImran Khan opens up on his comparisons to Ranbir Kapoor: 'I never considered...'May 11, 2024 | msn.com$19 for a FULL YEAR of stock picks?!Invest in Musk's AI Play With Just $100 You don't need deep pockets to ride the next wave of AI wealth. Discover how a $100 investment could give you exposure to Musk's private AI project — via one overlooked stock.May 24, 2025 | Behind the Markets (Ad)Imara BlumeAugust 23, 2023 | health.usnews.comIMARA Inc. (IMRA) Stock Historical Prices & Data - Yahoo FinanceMarch 3, 2023 | finance.yahoo.comImara Announces Stockholder Approval of Merger With EnlivenFebruary 22, 2023 | finance.yahoo.comSHAREHOLDER ALERT: Weiss Law Reminds IMRA, TIG, FORG, and BRBW Shareholders About Its Ongoing InvestigationsJanuary 5, 2023 | benzinga.comImara 10% Owner Trades $336K In Company StockOctober 25, 2022 | benzinga.comSee More Headlines IMRA Stock Analysis - Frequently Asked Questions How were IMARA's earnings last quarter? IMARA Inc. (NASDAQ:IMRA) issued its quarterly earnings results on Tuesday, November, 9th. The company reported ($2.20) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($3.64) by $1.44. When did IMARA's stock split? IMARA's stock reverse split on Friday, February 24th 2023. The 1-4 reverse split was announced on Friday, February 24th 2023. The number of shares owned by shareholders was adjusted after the market closes on Friday, February 24th 2023. An investor that had 100 shares of stock prior to the reverse split would have 25 shares after the split. When did IMARA IPO? IMARA (IMRA) raised $76 million in an initial public offering on Thursday, March 12th 2020. The company issued 4,500,000 shares at $16.00-$18.00 per share. Morgan Stanley, Citigroup and SVB Leerink served as the underwriters for the IPO. What other stocks do shareholders of IMARA own? Based on aggregate information from My MarketBeat watchlists, some other companies that IMARA investors own include NIO (NIO), Novavax (NVAX), NVIDIA (NVDA), Axsome Therapeutics (AXSM), Alibaba Group (BABA), AMC Entertainment (AMC) and BioXcel Therapeutics (BTAI). Company Calendar Last Earnings11/09/2021Today5/24/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Pharmaceutical preparations Sub-IndustryN/A Current SymbolNASDAQ:IMRA CIK1672619 Webwww.imaratx.com PhoneN/AFaxN/AEmployees41Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)$0.05 Trailing P/E Ratio944.31 Forward P/E RatioN/A P/E GrowthN/ANet Income$1.49 million Net MarginsN/A Pretax MarginN/A Return on Equity2.12% Return on Assets2.00% Debt Debt-to-Equity RatioN/A Current Ratio48.98 Quick Ratio48.98 Sales & Book Value Annual SalesN/A Price / SalesN/A Cash Flow$0.63 per share Price / Cash Flow75.24 Book Value$3.44 per share Price / Book13.72Miscellaneous Outstanding Shares26,234,000Free Float16,449,000Market Cap$1.24 billion OptionableNot Optionable Beta1.09 A Beginner's Guide to Investing in CannabisUnlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.Get This Free Report This page (NASDAQ:IMRA) was last updated on 5/24/2025 by MarketBeat.com Staff From Our PartnersMarket chaos is the new normalIt happened again. Wall Street swung like a wrecking ball after Trump paused tariffs on smartphones, lapto...Augusta Precious Metals | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | Sponsored$19 for a FULL YEAR of stock picks?!Invest in Musk's AI Play With Just $100 You don't need deep pockets to ride the next wave of AI wealth. ...Behind the Markets | SponsoredAfter Monday, price goes up 600% (hurry)Right now, for a limited time… You can get up to 52 Money Monday trades for just $7! Thanks to Wall Street’...Timothy Sykes | SponsoredMemorial Day Sale! 82% Off Disruptors and Dominators!Jensen Huang recently gave the keynote speech at the Consumer Electronics Show in Las Vegas. When the Nvidi...Weiss Ratings | SponsoredTrump Quietly Planning $15 Trillion Crypto ShockerMost investors are still unaware, but I believe a new White House action may have quietly opened the floodgate...Paradigm Press | SponsoredElon just did WHAT!?As you may recall, Biden and the Fed were working on a central bank digital currency, or CBDC. Had they got...Brownstone Research | SponsoredSilicon Valley Gold RushA new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding IMARA Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share IMARA With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.